Neurology® 2009;73:1 A reliable biomarker for HIV-associated dementia (HIV-D) has eluded neuro-AIDS investigators for more than 2 decades. An urgent need remains, because although the incidence of HIV-D has declined among patients treated with highly active antiretroviral therapy, prevalence has increased, and a more insidious cognitive decline, minor cognitive motor disorder (MC/MD), has becom...